Friday, October 24, 2025 7:30:54 AM
$12.17.. Genenta Science S.p.A. (GNTA) reported a net loss of approximately $9.23 million in its most recent quarter, according to the latest available income statement data. This confirms the company's continued lack of profitability in its recent financial performance
Recent GNTA News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/29/2026 08:05:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/19/2026 09:08:11 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 05/05/2026 08:39:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 08:05:02 PM
- Genenta signs Definitive Agreements with Sophia High Tech • GlobeNewswire Inc. • 04/23/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/14/2026 08:05:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:05:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 10:10:25 AM
- Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs • GlobeNewswire Inc. • 03/27/2026 09:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:39:04 PM
- Genenta Science evaluates biotech partnerships as it shifts strategic focus • IH Market News • 03/24/2026 10:41:04 AM
- Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini • GlobeNewswire Inc. • 03/24/2026 07:26:56 AM
- Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University • GlobeNewswire Inc. • 03/13/2026 09:00:00 AM
- Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform • GlobeNewswire Inc. • 02/27/2026 09:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/27/2026 11:10:58 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/27/2026 11:05:38 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/27/2026 11:03:51 AM
- Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator • GlobeNewswire Inc. • 01/27/2026 08:00:00 AM
- Genenta Science Provides Update on CEO Ownership • GlobeNewswire Inc. • 12/19/2025 07:30:00 AM
- Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial • GlobeNewswire Inc. • 11/24/2025 09:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/28/2025 05:20:21 PM
